-
Importance of Decisional Context in the Health Technology Assessment (HTA) of Ultra-Orphan Drugs
Sep 9, 2025, 16:22 PM -
Adjuvanted RSVpreF3 Vaccine for Respiratory Syncytial Virus Prevention in the United Kingdom, Spain, and Australia: A Climate Change Impact Analysis
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Evaluation of Combined Cervical Cancer Screening With CINtec PLUS in the Czech Republic
Sep 9, 2025, 16:22 PM -
The Use of Real-World Evidence in Health Technology Assessment and the Application of the NICE RWE Framework: A Review of NICE Technology Appraisals
Sep 9, 2025, 16:22 PM -
Unseen Burdens of Glycogen Storage Disease Type Ia (GSDIa) Experienced by Patients, Caregivers, and their Healthcare Team
Sep 9, 2025, 16:22 PM -
The Hidden Clinical and Economic Costs of PPI Treatment Failures in Severe Erosive Esophagitis
Sep 9, 2025, 16:22 PM -
Mutagenicity of Imazalil, Pyrimethanil, and Thiabendazole With and Without Citrus Oil
Sep 9, 2025, 16:22 PM -
Evaluating the Cost-Effectiveness of Adjuvanted Influenza Vaccine in the Older Adult Population in the Netherlands
Sep 9, 2025, 16:22 PM -
Treatment Patterns and Healthcare Resource Utilization in Patients With Chronic Inflammatory Demyelinating Polyneuropathy in England: A Retrospective, Observational Cohort Study
Sep 9, 2025, 16:22 PM -
Equivalence of Measurement Properties of the Dermatology Life Quality Index (DLQI) Across 13 European Countries
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of the AlloMap® Test for the Monitoring of Patients After Heart Transplantation: Economic Evaluation Alongside the CUPIDON Trial
Sep 9, 2025, 16:22 PM -
Exploring the Integration of Artificial Intelligence in Health Economic, Systematic Review, and Evidence Synthesis Methods: A Scoping Review of NICE Technology Appraisal and Assessment Reports
Sep 9, 2025, 16:22 PM -
Characterizing Exploratory Endpoints in Early Oncology Trials: Insights From Trial Registry Audit
Sep 9, 2025, 16:22 PM -
Review and Horizon Scanning of Advanced Therapy Medicinal Products in Slovenia: Registration, Reimbursement, and Future Pipeline
Sep 9, 2025, 16:22 PM -
Harnessing Generative Artificial Intelligence for Global Value Dossier Development
Sep 9, 2025, 16:22 PM -
Trends in Vaccination at Pharmacies by Race Among Medicaid Recipients: A Claims Analysis
Sep 9, 2025, 16:22 PM -
Predicting the Maximum Fair Price (MFP) From Medicare Negotiations
Sep 9, 2025, 16:22 PM -
Modeling Price Premiums of Oncology Drugs in Germany: A Cross-Validated Analysis Using XGBoost
Sep 9, 2025, 16:22 PM -
Disease Progression in Adults With Hepatitis Delta Virus vs. Hepatitis B Virus Monoinfection in Inpatient and Outpatient Settings in Italy
Sep 9, 2025, 16:22 PM -
Assessing Patient Access to Psoriasis Treatments in Central, South, and Eastern European Countries: Insights and Disparities?
Sep 9, 2025, 16:22 PM
